Business
Ventripoint Diagnostics Announces Collaboration with Summit Sciences
(TheNewswire) Engagement to develop economic and ROI models Toronto, Ontario – ...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Diagnostics Announces Collaboration with Summit Sciences\n(TheNewswire)\n\n\nEngagement to develop economic and\nROI models\n\n\nToronto, Ontario – TheNewswire - December 18, 2025 -\nVentripoint Diagnostics Ltd. (\"Ventripoint\" or\nthe \"Company\"), (TSXV:VPT; OTC:VPTDF) a leader in AI-enhanced\ncardiac imaging solutions, today announced the engagement of Dana\nFriesen and Summit Sciences, a specialized consulting firm, to create\nmore sophisticated, customer-centric financial and\nreturn-on-investment (ROI) models. This strategic partnership aims to\nequip healthcare providers with enhanced tools to evaluate the\neconomic benefits of adopting Ventripoint's innovative VMS+\ntechnology for cardiac diagnostics.\n\n\nThe collaboration will focus on refining financial\nmodeling frameworks that highlight the cost savings, operational\nefficiencies, and clinical outcomes associated with Ventripoint's\nAI-driven 3D heart modeling system. By integrating advanced analytics\nand real-world data, the new models will provide tailored insights for\nhospitals, clinics, and cardiology practices, demonstrating clear ROI\nthrough process improvement, better accuracy in heart assessments, and\noptimized resource allocation.\n\n\n\"We are excited to partner with Dana and Summit\nSciences to elevate our financial modeling capabilities,\" said\nHugh MacNaught, President & CEO of Ventripoint Diagnostics.\n\"Dana's extensive expertise in healthcare transformation,\ncombined with Summit Sciences' proven track record in data-driven\nconsulting, will enable us to deliver even more compelling value\npropositions to our customers. This initiative underscores our\ncommitment to not only advancing cardiac care through technology but\nalso ensuring that our solutions make strong economic sense for\nhealthcare providers worldwide.\"\n\n\n“We believe that Ventripoint’s VMS+ system can\nprovide real benefits to patients, healthcare providers, and\npayors,” commented Dana Friesen, CEO of Summit Sciences. “By\ncreating new models based on real-world data, Ventripoint will be able\nto accelerate the pace of commercializing VMS+ while expanding global\naccess to advanced cardiac imaging. Our history of working in\npartnership with a variety of partners and delivery models, including\nindigenous health networks and ...